Clinical Trials Browser

Phase 2 × INDUSTRY × Metastatic Castration-resistant Prostate Cancer, MCRPC × Clear all

NCT06890832 2025-03-24

A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer

Phase 2 Not yet recruiting

Metastatic Castration-resistant Prostate Cancer, MCRPC